XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3Close
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
OPERATING CASH FLOW    
Net earnings $ 119 $ 105
Adjustments to reconcile net earnings to operating cash flow:    
Impairment 0 (63)
Depreciation and amortization 57 55
(Earnings) loss from equity method investments, net of distributions (14) (14)
(Gain) loss on sales of assets (including AMECO-South America in 2023) 58 (15)
Stock-based compensation 37 19
Deferred taxes (14) (10)
Changes in assets and liabilities (334) (88)
Other (5) (4)
Operating cash flow (96) (15)
INVESTING CASH FLOW    
Purchases of marketable securities (250) (313)
Proceeds from sales and maturities of marketable securities 260 286
Capital expenditures (71) (38)
Proceeds from sales of assets (including AMECO-South America in 2023) 23 29
Investments in partnerships and joint ventures (13) (47)
Other 5 19
Investing cash flow (46) (64) Close
FINANCING CASH FLOW    
Proceeds from issuance of 2029 Notes, net of issuance costs 560 0
Capped call transactions related to 2029 Notes (73) 0
Purchases and retirement of debt (249) (23)
Proceeds from NuScale de-SPAC transaction 0 341
Proceeds from sale of NuScale interest 0 107
Dividends paid on CPS (29) (29)
Make-whole payment on conversion of CPS (27) 0
Distributions paid to NCI (41) (15)
Capital contributions by NCI 5 0
Other (15) (3)
Financing cash flow 131 378 Close
Effect of exchange rate changes on cash (7) (72) Close
Increase (decrease) in cash and cash equivalents (18) 227 Close
Cash and cash equivalents at beginning of period 2,439 2,209
Cash and cash equivalents at end of period 2,421 2,436
SUPPLEMENTAL INFORMATION:    
Cash paid for interest 46 43
Cash paid for income taxes (net of refunds) $ 129 $ 71